₹251
(Inclusive of all Taxes)
₹37.6 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
Manufacturer/Marketer :
Lloyd Healthcare Pvt Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Bylenta MLN 50 Tablet:
Co-administration of Aliskiren with Bylenta MLN 50 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Bylenta MLN 50 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Bylenta MLN 50 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Bylenta MLN 50 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking lisinopril with Bylenta MLN 50 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Taking lisinopril with Bylenta MLN 50 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking quinapril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanEluxadoline
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Co-administration of Bylenta MLN 50 Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Bylenta MLN 50 Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Co-administration of Bylenta MLN 50 Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Bylenta MLN 50 Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Coadministration of enalapril with Bylenta MLN 50 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Bylenta MLN 50 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Bylenta MLN 50 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Bylenta MLN 50 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
TelmisartanPotassium acetate
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Co-administration of Potassium acetate can make Bylenta MLN 50 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Bylenta MLN 50 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Co-administration of Potassium acetate can make Bylenta MLN 50 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Bylenta MLN 50 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking perindopril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking perindopril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Co-administration of Bylenta MLN 50 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Bylenta MLN 50 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking Potassium citrate with Bylenta MLN 50 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Bylenta MLN 50 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Bylenta MLN 50 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Bylenta MLN 50 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking ramipril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking ramipril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
Alcohol
Unsafe
Avoid consuming alcohol as it might cause increased dizziness.
Pregnancy
Consult your doctor
Please consult your doctor if you are pregnant; your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Consult your doctor
Please consult your doctor if you are breastfeeding; your doctor will decide whether Bylenta MLN 50 Tablet can be given to breastfeeding mothers or not.
Driving
Unsafe
Bylenta MLN 50 Tablet may cause dizziness, do not drive or operate heavy machinery if you feel dizzy.
Liver
Caution
Dose adjustment may be needed. Bylenta MLN 50 Tablet should be used with caution in patients with liver impairment/liver disease. Please consult your doctor if you have liver problems or any concerns regarding this.
Kidney
Caution
Dose adjustment may be needed. Bylenta MLN 50 Tablet should be used with caution in patients with kidney impairment/kidney disease. Please consult your doctor if you have kidney problems or any concerns regarding this.
Children
Unsafe
Bylenta MLN 50 Tablet is not recommended for children as safety and effectiveness have not been established.
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
